CL2018001692A1 - Un método para la fabricación de un anillo vaginal - Google Patents

Un método para la fabricación de un anillo vaginal

Info

Publication number
CL2018001692A1
CL2018001692A1 CL2018001692A CL2018001692A CL2018001692A1 CL 2018001692 A1 CL2018001692 A1 CL 2018001692A1 CL 2018001692 A CL2018001692 A CL 2018001692A CL 2018001692 A CL2018001692 A CL 2018001692A CL 2018001692 A1 CL2018001692 A1 CL 2018001692A1
Authority
CL
Chile
Prior art keywords
manufacturing
vaginal ring
ring
siloxane elastomer
vaginal
Prior art date
Application number
CL2018001692A
Other languages
English (en)
Inventor
Lasse Koivula
Original Assignee
Bayer Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55024875&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2018001692(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Oy filed Critical Bayer Oy
Publication of CL2018001692A1 publication Critical patent/CL2018001692A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29DPRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D99/00Subject matter not provided for in other groups of this subclass
    • B29D99/0082Producing articles in the form of closed loops, e.g. rings
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2083/00Use of polymers having silicon, with or without sulfur, nitrogen, oxygen, or carbon only, in the main chain, as moulding material
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2105/00Condition, form or state of moulded material or of the material to be shaped
    • B29K2105/24Condition, form or state of moulded material or of the material to be shaped crosslinked or vulcanised
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2509/00Use of inorganic materials not provided for in groups B29K2503/00 - B29K2507/00, as filler
    • B29K2509/08Glass
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2995/00Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
    • B29K2995/0037Other properties
    • B29K2995/0088Molecular weight

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Mechanical Engineering (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Pregnancy & Childbirth (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a un método para la manufactura de un anillo vaginal, donde el anillo vaginal comprende al menos un agente terapéuticamente activo y un cuerpo que comprende un elastómero de siloxano entrecruzado. El método comprende manufacturar el cuerpo en forma de una varilla que tiene un primer extremo y un segundo extremo y dar forma al cuerpo para obtener un anillo colocando una pieza de unión entre el primer extremo del cuerpo y el segundo extremo del cuerpo, donde la pieza de unión comprende un elastómero de siloxano no entrecruzado que tiene un peso molecular promedio en peso de 650-850 g/mol y un catalizador de entrecruzamiento, y curado de la pieza de unión durante un período de tiempo de 1-30 segundos utilizando una temperatura de 125-220°C.
CL2018001692A 2015-12-21 2018-06-21 Un método para la fabricación de un anillo vaginal CL2018001692A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15201507 2015-12-21

Publications (1)

Publication Number Publication Date
CL2018001692A1 true CL2018001692A1 (es) 2018-10-05

Family

ID=55024875

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2018001692A CL2018001692A1 (es) 2015-12-21 2018-06-21 Un método para la fabricación de un anillo vaginal

Country Status (20)

Country Link
US (1) US20200276110A1 (es)
EP (1) EP3393450A1 (es)
JP (1) JP2019504021A (es)
KR (1) KR20180093255A (es)
CN (1) CN108472248A (es)
AR (1) AR107169A1 (es)
AU (1) AU2016375427A1 (es)
BR (1) BR112018012744A2 (es)
CA (1) CA3008940A1 (es)
CL (1) CL2018001692A1 (es)
CO (1) CO2018006394A2 (es)
HK (1) HK1254072A1 (es)
IL (1) IL259625A (es)
MX (1) MX2018007674A (es)
PE (1) PE20181431A1 (es)
RU (1) RU2018126790A (es)
SG (1) SG11201805112WA (es)
TW (1) TW201725243A (es)
UY (1) UY37044A (es)
WO (1) WO2017108671A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019051579A1 (en) * 2017-09-18 2019-03-21 Sham Derek METHODS AND SYSTEMS FOR ADJUSTING VAGINAL THERAPEUTIC DEVICE

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4155991A (en) * 1974-10-18 1979-05-22 Schering Aktiengesellschaft Vaginal ring
IL48277A (en) * 1974-10-18 1978-03-10 Schering Ag Vaginal ring
ZA857643B (en) * 1984-10-12 1986-05-28 Akzo Nv Release system for two or more active substances
CN1264488C (zh) * 2003-05-14 2006-07-19 上海市计划生育科学研究所 阴道环简易制备方法
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
EP2062568A1 (en) * 2007-11-22 2009-05-27 Bayer Schering Pharma Oy Vaginal delivery system
ATE508734T1 (de) * 2007-11-22 2011-05-15 Bayer Oy System zur vaginalen freisetzung
DK2249757T3 (en) * 2008-02-04 2017-10-16 Ferring Bv Monolithic vaginal rings comprising progesterone and methods of preparation and use thereof.
WO2010054296A2 (en) * 2008-11-07 2010-05-14 Combinent Biomedical Systems, Inc. Devices and methods for treating and/or preventing diseases
US8580294B2 (en) * 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
TWI615155B (zh) * 2011-11-01 2018-02-21 拜耳股份有限公司 滲透活性的陰道遞送系統
AR089765A1 (es) * 2012-01-23 2014-09-17 Bayer Oy Un sistema para el suministro de un farmaco
US10137031B2 (en) * 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings

Also Published As

Publication number Publication date
BR112018012744A2 (pt) 2018-12-04
CO2018006394A2 (es) 2018-07-10
WO2017108671A1 (en) 2017-06-29
UY37044A (es) 2017-07-31
PE20181431A1 (es) 2018-09-12
CN108472248A (zh) 2018-08-31
RU2018126790A3 (es) 2020-05-21
KR20180093255A (ko) 2018-08-21
HK1254072A1 (zh) 2019-07-12
AR107169A1 (es) 2018-03-28
RU2018126790A (ru) 2020-01-23
CA3008940A1 (en) 2017-06-29
TW201725243A (zh) 2017-07-16
SG11201805112WA (en) 2018-07-30
MX2018007674A (es) 2018-09-12
US20200276110A1 (en) 2020-09-03
IL259625A (en) 2018-07-31
AU2016375427A1 (en) 2018-06-21
EP3393450A1 (en) 2018-10-31
JP2019504021A (ja) 2019-02-14

Similar Documents

Publication Publication Date Title
CY1123065T1 (el) Ανασυνδυασμενα προβιοτικα βακτηριδια
EA201270433A1 (ru) Лечение аутоиммунных и воспалительных заболеваний эпратузумабом
BR112015030514A2 (pt) Composições e métodos para conjugação de anticorpos ativáveis
CL2016002372A1 (es) Cenicriviroc para el tratamiento de la fibrosis.
CR20170031A (es) Composiciones de portador-anticuerpo y métodos para realizarlas y utilizarlas
JP2016529227A5 (ja) 受容体媒介クリアランスが減少した、生理活性ポリペプチド単量体と免疫グロブリンFc断片との結合体及びその製造方法
NI201000044A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
CL2018000597A1 (es) Métodos para tratar enfermedades inflamatorias
DE102019201181B8 (de) Fahrzeugkarosseriestruktur
BR112017002774A2 (pt) método e sistema para criar uma dobra em um corpo feito de material expansível
UY36961A (es) Receptores celulares universales programables y métodos para usar los mismos
BR112018009066A8 (pt) copolímero de propileno heterofásico, composição de poliolefina, artigo automotivo, processo para preparação de uma composição de poliolefina, e, uso de um copolímero de propileno heterofásico.
ES2666382T8 (es) Ortesis activa para la rehabilitación neurológica del movimiento de los miembros inferiores, sistema que comprende dicha órtesis y proceso para poner en funcionamiento dicho sistema
BR112018008670A2 (pt) copolímero de propileno heterofásico, composição de poliolefina, artigo automotivo, processo para a preparação de uma composição de poliolefina, e, uso do copolímero de propileno heterofásico.
CO2017001626A2 (es) Anticuerpo anti-orai1
BR112012012902A2 (pt) gaiola do mancal de esferas
CO2018006394A2 (es) Un método para la fabricación de un anillo vaginal
MX2015005045A (es) Vacuna para prevenir la enfermedad de edema porcino.
EA201990768A1 (ru) Оптимизированные синтетические консенсусные иммуногенные композиции, нацеленные на белок активации фибробластов
BR112017018602A8 (pt) Método para encher um conjunto de silenciador com um material fibroso
CO2018012110A2 (es) Procedimiento para la preparación de cuerpos moldeados para la administración a animales
DE112018006371A5 (de) Hybridgetriebe sowie Fahrzeug mit dem Hybridgetriebe
CY1124482T1 (el) Μεθοδος κατασκευης κυστης
CL2019001570A1 (es) Uña postiza y un método para su conformación sobre una uña natural.
ES2744026R1 (es) Disposición de toma de potencia, tren motriz y vehículo.